oral glutathione bioavailability randomized trial richie 2015 Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease Targeted prevention of radiation-induced oral
Description
Dini L, Autuori F, Lentini A, Oliverio S, Piacentini M
Biofactors 48 (2), 400415
2001 Fall;14(3):301-7
In some embodiments, the otic formulation or composition comprises between about 0.001% to about 50% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
